Type 2 DM (DM-II) accounts for 90–95% of all DM cases and is a progressive metabolic disorder characterized by resistance to insulin effects and abnormal insulin production to maintain blood glucose levels [10, 11], presenting a complex and multifactorial etiology [12, 13, 14, 15]. The gene discussed is INS; the disease is metabolic disease.